Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy
ISRN AIDS · 2013
DOI: 10.1155/2013/358294 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN AIDS, 2013. Verfasst von Christos Tsoukas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, McGill University Health Centre, Room A5-140, 1650 Cedar Avenue, Montreal, QC, Canada H3G 1A4. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Objective
During the course of HIV infection, progressive immune deficiency occurs. The aim of this prospective substudy was to evaluate the recovery of functional immunity in a subset of patients from the GRACE (Gender, Race, And Clinical Experience) study treated with a DRV/r-based regimen.
Methods
The recovery of functional immunity with a darunavir/ritonavir-based regimen was assessed in a subset of treatment-experienced, HIV-1 infected patients from the GRACE study.
Results
19/32 patients (59%) enrolled in the substudy were virologically suppressed (
Autor:innen und Institutionen
- Department of Microbiology and Immunology, McGill University Health Centre, Room A5-140, 1650 Cedar Avenue, Montreal, QC, Canada H3G 1A4.
- Montreal General Hospital, Flowcytometry Laboratory, 1650 Cedar Avenue, Room C10-166, Montreal, QC, Canada H3G 1A4.
- LAC+USC Medical Center, 1200 N State Street, Room IPT-C4E100, Los Angeles, CA 90033, USA.
- Janssen Services, LLC, Clinical Affairs, 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA.
Zitieren
APA
Tsoukas, C., Gilbert, L., Lewis, T., Hatzakis, G., Falcon, R., & Mrus, J. (2013). Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS. https://doi.org/10.1155/2013/358294
Vancouver
Tsoukas C, Gilbert L, Lewis T, Hatzakis G, Falcon R, Mrus J. Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS. 2013. doi:10.1155/2013/358294
BibTeX
@article{Tsoukas2013,
author = {Tsoukas, Christos and Gilbert, Louise and Lewis, Trevor and Hatzakis, George and Falcon, Ron and Mrus, Joseph},
title = {Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy},
journal = {ISRN AIDS},
year = {2013},
doi = {10.1155/2013/358294}
}
EUVIMED